Pledge Therapeutics

Pledge Therapeutics is a biotechnology company based in Canton, Massachusetts, specializing in the research and development of transformative therapies in immunology and virology. The company leverages advanced biophysical and structural technologies to design novel treatments, focusing on antivirals, anti-infectives, and immuno-oncology. As an innovative startup, Pledge Therapeutics is dedicated to advancing drug discovery from early hits to preclinical candidates, contributing to significant scientific discoveries. The company operates with a team of 10-50 employees and participates in industry conventions, highlighting its commitment to cutting-edge therapeutic research and development.

Recent Posts by Pledge Therapeutics

1-1 of 1